Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T16:29:08.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH website transition and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T16:39:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T21:52:29.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T04:22:29.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the prior study record content. The page also adds a Home link and revision note while removing extensive study details and related terms.
    Difference
    18%
    Check dated 2026-09-21T22:24:22.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    No textual changes were detected on the page; the study details and related information remain as published. The overall presentation and structure appear unchanged.
    Difference
    0.1%
    Check dated 2026-09-07T20:59:34.000Z thumbnail image

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.